Abstract
HTA126 How Did French Health Technology Assessment Body (Transparency Committee, TC, of the HAS) Assess Drugs with Clinical Development Based on Single Arm Trials in the Last Three Years?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
